(R)-N-ethyl-5-fluoro-N-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-methylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide besylate salt
The present invention relates to (R)-N-ethyl-5-fluoro-N-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-methylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide besylate salt and solvates thereof. This compound may be useful for therapy and/or prophylaxis in a mammal...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CLEATOR, EDWARD SMOLDERS, SIMON JAN C BEN HAIM, CYRIL DARVILLE, NICOLAS FREDDY J GEERTMAN, ROBERT MICHAEL LIU, YING-TAO NG, ALICIA TEE FUAY QUEROLLE, OLIVIER ALEXIS GEORGES AHUJA, DIPALI THURING, JOHANNES WILHELMUS J CAI, WEI PANDE, VINEET DAI, XUEDONG |
| description | The present invention relates to (R)-N-ethyl-5-fluoro-N-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-methylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide besylate salt and solvates thereof. This compound may be useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compound, and use as menin/MLL protein/protein interaction inhibitor, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW202315636A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW202315636A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW202315636A3</originalsourceid><addsrcrecordid>eNqNjEEKwjAQRbtxIeoddJdCRzRpsxdRXLkQwYVIiXbEQNoJTQTroTyjg3oAV2_478_vJy-xS2ELGG-dgwKu7k4tcWAD-ZY8hxKEKEAwNF8Sau7So_t8pKL-0tS2oRS-tnM3fJgGFLABmWmorHma4G1LRzXNT3SJrPVHzzOZ5RBbbthfxuvpGZsnj1Y4PmPonIk4DsbFYdK7Ghdw9OMgmaxX--UG0FOJwZsLNhjL_UHOpJoXWumF-qfzBklTU80</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>(R)-N-ethyl-5-fluoro-N-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-methylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide besylate salt</title><source>esp@cenet</source><creator>CLEATOR, EDWARD ; SMOLDERS, SIMON JAN C ; BEN HAIM, CYRIL ; DARVILLE, NICOLAS FREDDY J ; GEERTMAN, ROBERT MICHAEL ; LIU, YING-TAO ; NG, ALICIA TEE FUAY ; QUEROLLE, OLIVIER ALEXIS GEORGES ; AHUJA, DIPALI ; THURING, JOHANNES WILHELMUS J ; CAI, WEI ; PANDE, VINEET ; DAI, XUEDONG</creator><creatorcontrib>CLEATOR, EDWARD ; SMOLDERS, SIMON JAN C ; BEN HAIM, CYRIL ; DARVILLE, NICOLAS FREDDY J ; GEERTMAN, ROBERT MICHAEL ; LIU, YING-TAO ; NG, ALICIA TEE FUAY ; QUEROLLE, OLIVIER ALEXIS GEORGES ; AHUJA, DIPALI ; THURING, JOHANNES WILHELMUS J ; CAI, WEI ; PANDE, VINEET ; DAI, XUEDONG</creatorcontrib><description>The present invention relates to (R)-N-ethyl-5-fluoro-N-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-methylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide besylate salt and solvates thereof. This compound may be useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compound, and use as menin/MLL protein/protein interaction inhibitor, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes.</description><language>chi ; eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230416&DB=EPODOC&CC=TW&NR=202315636A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230416&DB=EPODOC&CC=TW&NR=202315636A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CLEATOR, EDWARD</creatorcontrib><creatorcontrib>SMOLDERS, SIMON JAN C</creatorcontrib><creatorcontrib>BEN HAIM, CYRIL</creatorcontrib><creatorcontrib>DARVILLE, NICOLAS FREDDY J</creatorcontrib><creatorcontrib>GEERTMAN, ROBERT MICHAEL</creatorcontrib><creatorcontrib>LIU, YING-TAO</creatorcontrib><creatorcontrib>NG, ALICIA TEE FUAY</creatorcontrib><creatorcontrib>QUEROLLE, OLIVIER ALEXIS GEORGES</creatorcontrib><creatorcontrib>AHUJA, DIPALI</creatorcontrib><creatorcontrib>THURING, JOHANNES WILHELMUS J</creatorcontrib><creatorcontrib>CAI, WEI</creatorcontrib><creatorcontrib>PANDE, VINEET</creatorcontrib><creatorcontrib>DAI, XUEDONG</creatorcontrib><title>(R)-N-ethyl-5-fluoro-N-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-methylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide besylate salt</title><description>The present invention relates to (R)-N-ethyl-5-fluoro-N-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-methylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide besylate salt and solvates thereof. This compound may be useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compound, and use as menin/MLL protein/protein interaction inhibitor, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjEEKwjAQRbtxIeoddJdCRzRpsxdRXLkQwYVIiXbEQNoJTQTroTyjg3oAV2_478_vJy-xS2ELGG-dgwKu7k4tcWAD-ZY8hxKEKEAwNF8Sau7So_t8pKL-0tS2oRS-tnM3fJgGFLABmWmorHma4G1LRzXNT3SJrPVHzzOZ5RBbbthfxuvpGZsnj1Y4PmPonIk4DsbFYdK7Ghdw9OMgmaxX--UG0FOJwZsLNhjL_UHOpJoXWumF-qfzBklTU80</recordid><startdate>20230416</startdate><enddate>20230416</enddate><creator>CLEATOR, EDWARD</creator><creator>SMOLDERS, SIMON JAN C</creator><creator>BEN HAIM, CYRIL</creator><creator>DARVILLE, NICOLAS FREDDY J</creator><creator>GEERTMAN, ROBERT MICHAEL</creator><creator>LIU, YING-TAO</creator><creator>NG, ALICIA TEE FUAY</creator><creator>QUEROLLE, OLIVIER ALEXIS GEORGES</creator><creator>AHUJA, DIPALI</creator><creator>THURING, JOHANNES WILHELMUS J</creator><creator>CAI, WEI</creator><creator>PANDE, VINEET</creator><creator>DAI, XUEDONG</creator><scope>EVB</scope></search><sort><creationdate>20230416</creationdate><title>(R)-N-ethyl-5-fluoro-N-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-methylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide besylate salt</title><author>CLEATOR, EDWARD ; SMOLDERS, SIMON JAN C ; BEN HAIM, CYRIL ; DARVILLE, NICOLAS FREDDY J ; GEERTMAN, ROBERT MICHAEL ; LIU, YING-TAO ; NG, ALICIA TEE FUAY ; QUEROLLE, OLIVIER ALEXIS GEORGES ; AHUJA, DIPALI ; THURING, JOHANNES WILHELMUS J ; CAI, WEI ; PANDE, VINEET ; DAI, XUEDONG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW202315636A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CLEATOR, EDWARD</creatorcontrib><creatorcontrib>SMOLDERS, SIMON JAN C</creatorcontrib><creatorcontrib>BEN HAIM, CYRIL</creatorcontrib><creatorcontrib>DARVILLE, NICOLAS FREDDY J</creatorcontrib><creatorcontrib>GEERTMAN, ROBERT MICHAEL</creatorcontrib><creatorcontrib>LIU, YING-TAO</creatorcontrib><creatorcontrib>NG, ALICIA TEE FUAY</creatorcontrib><creatorcontrib>QUEROLLE, OLIVIER ALEXIS GEORGES</creatorcontrib><creatorcontrib>AHUJA, DIPALI</creatorcontrib><creatorcontrib>THURING, JOHANNES WILHELMUS J</creatorcontrib><creatorcontrib>CAI, WEI</creatorcontrib><creatorcontrib>PANDE, VINEET</creatorcontrib><creatorcontrib>DAI, XUEDONG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CLEATOR, EDWARD</au><au>SMOLDERS, SIMON JAN C</au><au>BEN HAIM, CYRIL</au><au>DARVILLE, NICOLAS FREDDY J</au><au>GEERTMAN, ROBERT MICHAEL</au><au>LIU, YING-TAO</au><au>NG, ALICIA TEE FUAY</au><au>QUEROLLE, OLIVIER ALEXIS GEORGES</au><au>AHUJA, DIPALI</au><au>THURING, JOHANNES WILHELMUS J</au><au>CAI, WEI</au><au>PANDE, VINEET</au><au>DAI, XUEDONG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>(R)-N-ethyl-5-fluoro-N-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-methylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide besylate salt</title><date>2023-04-16</date><risdate>2023</risdate><abstract>The present invention relates to (R)-N-ethyl-5-fluoro-N-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-methylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide besylate salt and solvates thereof. This compound may be useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compound, and use as menin/MLL protein/protein interaction inhibitor, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_TW202315636A |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | (R)-N-ethyl-5-fluoro-N-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-methylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide besylate salt |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T13%3A24%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CLEATOR,%20EDWARD&rft.date=2023-04-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW202315636A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |